Get the Stockscreener App
3.65
2.14%
-0.08
After Hours:
3.65
Sophia Genetics Sa stock is traded at $3.65, with a volume of 24,156.
It is down -2.14% in the last 24 hours and down -4.95% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$3.73
Open:
$3.75
24h Volume:
24,156
Relative Volume:
0.42
Market Cap:
$246.30M
Revenue:
$62.37M
Net Income/Loss:
$-78.98M
P/E Ratio:
-2.9918
EPS:
-1.22
Net Cash Flow:
$-57.80M
1W Performance:
-4.70%
1M Performance:
-4.95%
6M Performance:
-25.96%
1Y Performance:
+43.42%
1-Day Range:
$3.57
$3.84
1-Week Range:
$3.57
$4.10
52-Week Range:
$2.45
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 52.0% in September - Defense World
Global Precision medicine software Market Expected to Reach $ 3112.52 Million by 2032, Growing at 11.4% CAGR - 대구포스트
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
The Agenda Setter: SOPHIE’s posthumous new album cements a pop visionary’s legacy - Dork Magazine
Sosandar – AGM Due On Thursday For Women’s Fashion Group Now Recovering Into Profits, Shares Now 10p, Brokers Predict 31p - UK Investor Magazine
Sophie's life was saved by a stranger. Some in her position have an 'unfair' disadvantage - SBS News
No luck for McDonald after another concussion setback - Albany Advertiser
‘My first impression was this person’s a genius’: the life and legacy of producer pioneer Sophie - The Guardian
Tracklist of SOPHIE's Posthumous Album Revealed - EDM.com
‘Extra proud’: Lions rookie reflects on AFLW rise - Sunshine Coast Daily
SOPHiA Presents Multimodal AI-Driven Research on Patient Stratification in Lung Cancer - Inside Precision Medicine
Tracklist Unveiled For Posthumous SOPHIE Album - Stereoboard
Sofia Connelly’s vintage store Pecorina is a love letter to Italy, in Australia - Fashion Journal
SOPHiA GENETICS presents ground-breaking multimodal research on AI-driven patient stratification at ESMO 2024 - EurekAlert
SOPHiA GENETICS Unveils AI Patient Research at ESMO 2024 - Mirage News
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 - StockTitan
SOPHiA GENETICS announces poster presentations at ESMO 2024 - EurekAlert
SOPHiA GENETICS (Nasdaq: SOPH) [IMAGE] - EurekAlert
SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 - StockTitan
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 - Marketscreener.com
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 - StockTitan
Sophia Genetics maintains Buy stock rating after roundtable insights - Investing.com
Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout - Medical Device Network
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - Barchart
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Bought by Principal Financial Group Inc. - Defense World
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Purchased by Principal Financial Group Inc. - MarketBeat
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - Financial Times
SOPHiA GENETICS (IMAGE) - EurekAlert
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 - StockTitan
SOPHiA GENETICS announces validation of novel - EurekAlert
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 - Yahoo Finance
SOPHSOPHiA GENETICS SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Banque Cantonale Vaudoise Purchases 9,000 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024 - Quantisnow
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024 - StockTitan
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference – Company AnnouncementFT.com - Financial Times
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decline in Short Interest - MarketBeat
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
AI in Bioinformatics Global Market Innovations Investigated by Key Trends Strategic Insights and Growth Opportunities - WhaTech
AI in Bioinformatics Global Market Innovations Investigated by Key Trends Strategic Insights and Growth Opp... - WhaTech
SOPHiA GENETICS Reports Second Quarter 2024 Results - Kilgore News Herald
Sophia Genetics secures CE mark for DDM analytics platform under EU’s IVDR - Medical Device Network
SOPHiA DDM™ Platform Certified Under IVDR - Marketscreener.com
SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH) PT Lowered to $7.00 at Royal Bank of Canada - Defense World
What Makes SOPHiA GENETICS (SOPH) a New Buy Stock - MSN
What Makes SOPHiA GENETICS (SOPH) a New Buy Stock - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target - Simply Wall St
Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH) - Simply Wall St
SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):